Skip to main content
. 2023 Jan 2;13:34. doi: 10.1038/s41598-022-26202-1

Figure 2.

Figure 2

The receiver operating characteristic (ROC) curve analysis of binding-specific antibody at 35% (A) and 90% (B) inhibition from SARS-CoV-2 NeutraLISA.